Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Curex vs HealthSource

By GLP-1 ScorecardUpdated

Curex
Site position #287

Lower grade

HealthSource
Site position #105

Higher grade

Score comparison

HealthSource has the higher recorded score — 71.2/100 to 63.4/100.

HealthSource grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueHealthSource +12
54
66
Dose & formulationHealthSource +8
75
83
Clinical oversightHealthSource +25
55
80
Labs & monitoringCurex +1
55
54
FulfillmentCurex +10
90
80
Contract termsCurex +6
61
55
Curex · top barHealthSource · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCurexHealthSource
WeighScore63.4/10071.2/100
GradeCC
Site position#287#105
Semaglutide$199/mo (compounded oral)$199/mo (all doses, compounded)
Tirzepatide$199/mo (compounded oral)$299/mo (all doses, compounded)
Coverage45 statesAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Curex

Site position #287 · C

FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.

Strengths

  • LegitScript certified
  • Named entity (Curex, Inc.) with two offices — Miami FL and NYC
  • No membership fee ever
  • Injectable and oral dissolving tablet formats
  • Third-party lab testing via FDA/DEA certified labs

What to consider

  • Not available in AK, AR, CT, HI, MA, NM, MO
  • Compounded only — explicitly states 'We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro'
  • Primary business is allergy immunotherapy — GLP-1 is a newer vertical
  • FDA issued Curex a warning letter in September 2025; the letter is public in FDA's warning-letter database
HealthSource

Site position #105 · C

Strengths

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

What to consider

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard